Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

J. Oldenburg1, S. D. Fosså1, J. Nuver2, A. Heidenreich3, H-J Schmoll4, C. Bokemeyer5, A. Horwich6, J. Beyer7 & V. Kataja8, on behalf of the ESMO Guidelines Working Group* Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; Department of Urology, RWTH University Hospital, Aachen; Department of Oncology/Haematology/Haemostaseology, University Hospital Halle, Halle; Department of Oncology, Haematology and Bone Marrow Transplantation with Section Pneumology, University Hospital, Hamburg, Germany; Department of Academic Radiotherapy, Institute of Cancer Research, Royal Marsden Hospital, Sutton Hospital, UK; Department of Haematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany; Cancer Centre, Kuopio University Hospital, Kuopio, Finland;